abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

12 Apr 2007

Sanford Lewis, on behalf of Amnesty Intl. USA

[PDF] Amnesty Intl. USA letter to US Securities & Exchange Commission re: Dow Chemical and Bhopal as investment impediment in India

We are writing to bring to your attention a document that we have just received that we believe raises significant concerns about the Company’s failure to disclose risks to shareholders, therefore warranting further investigation by the Securities and Exchange Commission... [The] document, which appears to be a letter from the Chairman and CEO of the Company, Andrew Liveris...reflects the ongoing reality that, despite Dow Chemical’s assertions to the contrary, the Bhopal legacy issue is not behind the Company... [C]onsidering the...importance of India..., we believe the impediment to investing in India owing to the unresolved liabilities in Bhopal may constitute a material matter that ought to have been previously disclosed by the management to shareholders.